The news: Two new sets of vaccine results announced today suggest the South African variant of the virus is proving harder to vaccinate against. Novavax and Johnson & Johnson both announced that final-stage clinical trials showed their vaccines are effective at preventing illness—but that this efficacy dropped when dealing with the variant sequenced in South…